Affinity Biosensors
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $14.4M
Overview
Affinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.
Diagnostics
Funding History
5Total raised:$14.4M
Series A$8M
Seed$3.2M
Seed$2M
Grant$500K